‘Nitric Oxide’ A Dual Performer in Dengue Virus Infection

Athavale, Prachi; Pandit, Dakshayani; Das, Nikunja

doi:10.30699/ijmm.16.6.537

year 16, Issue 6 (November - December 2022) Iran J Med Microbiol 2022, 16(6): 537-542 | Back to browse issues page

‎ 10.30699/ijmm.16.6.537

Mendeley

Zotero

RefWorks

Athavale P, Pandit D, Das N. ‘Nitric Oxide’ A Dual Performer in Dengue Virus Infection. Iran J Med Microbiol 2022; 16 (6) :537-542
URL: http://ijmm.ir/article-1-1705-en.html

‘Nitric Oxide’ A Dual Performer in Dengue Virus Infection

Prachi Athavale

¹, Dakshayani Pandit²

, Nikunja Das²

1- Department of Microbiology, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth, Pimpri, Pune, India , pvathavale@gmail.com
2- Department of Microbiology, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth, Pimpri, Pune, India

Abstract: (1382 Views)

Background and Aim: The study was conducted to assess the role of Nitric Oxide (NO) in the pathogenesis of Dengue fever (DF).
Materials and Methods: A total of 150 patients with positive Dengue serology and 50 candidates as controls in the age group of 15-65 years were included in the study. NO levels were measured by Griess Nitrate Method (Cadmium granules modified).
Results: The rise in NO was observed in 24 (20.86%) patients out of 115 DF patients, while it was raised in only 01 (2.8%) case out of 35 patients of DHF and the difference was observed to be statistically significant. NO level was within normal limits (Normal Range- 24.8-77.6µmol/L) in 92% (n=50) healthy controls and was raised in (NO value>77.66µmol/L) 4% healthy controls. A positive correlation was observed in the serum NO levels with platelet count. The majority of the patients in the study (41.33%) were in the age group of 21-30 years of age, followed by were < 20 yrs (30%) and 31-40 yrs (12.67%). Male:female ratio observed was 1.78:1. DF was diagnosed in 115 (76.67%) patients, while DHF was diagnosed in 35 (23.33%) patients, while no case of DSS was diagnosed.
Conclusion: NO plays a protective role in DF, while in DHF patients, the absence of rising NO levels may be one of the contributory factors leading to the progression of the disease and increased morbidity. NO levels can guide the physician about the evolution of a case of Dengue.

Keywords: Dengue Fever, Nitric Oxide, Dengue Hemorrhagic Fever, Griess Nitrite method

Full-Text [PDF 446 kb] (682 Downloads) | | Full-Text (HTML) (591 Views)

Type of Study: Original Research Article | Subject: Medical Virology
Received: 2022/03/25 | Accepted: 2022/07/12 | ePublished: 2022/09/9

References

1. Guzman M, Halstead S, Artsob H, Buchy P, Farrar J, Gubler D, et al. Dengue: a continuing global threat. Nat Rev Microbiol. 2010;8(S12):S7-16. [DOI:10.1038/nrmicro2460] [PMID] [PMCID]

2. Organization WH. Dengue guidelines for diagnosis, treatment, prevention and control 2009.

3. Habermehl G. Toxicon. Am J trop Med Hyg. 1983; 21(5):734. [DOI:10.1016/0041-0101(83)90293-3]

4. Sabchareon A, Sirivichayakul C, Limkittikul K, Chanthavanich P, Suvannadabba S, Jiwariyavej V, et al. Dengue Infection in Children in Ratchaburi, Thailand: A Cohort Study. I. Epidemiology of Symptomatic Acute Dengue Infection in Children, 2006-2009. PLoS Neglected Tropical Diseases. 2012;6(7):e1732. [DOI:10.1371/journal.pntd.0001732] [PMID] [PMCID]

5. Ignarro LJ. Signal transduction mechanisms involving nitric oxide. Biochem Pharmacol. 1991;41(4):485-90. [DOI:10.1016/0006-2952(91)90618-F]

6. Moncada S, Palmer RMJ, Higgs EA. Biosynthesis of nitric oxide from l-arginine: A pathway for the regulation of cell function and communication. Biochem Pharmacol. 1989;38(11):1709-15. [DOI:10.1016/0006-2952(89)90403-6]

7. Moncada S, Higgs A. The L-Arginine-Nitric Oxide Pathway. N Engl J Med. 1993;329(27):2002-12. [DOI:10.1056/NEJM199312303292706] [PMID]

8. Bogdan C. The Multiplex Function of Nitric Oxide in (Auto) immunity. J Exp Med. 1998;187(9): 1361-5. [DOI:10.1084/jem.187.9.1361] [PMID] [PMCID]

9. Akaike T, Maeda H. Nitric oxide and virus infection. Immunology. 2000;101(3):300-8. [DOI:10.1046/j.1365-2567.2000.00142.x] [PMID] [PMCID]

10. Akuta T, Zaki MH, Yoshitake J, Okamoto T, Akaike T. Nitrative stress through formation of 8-nitroguanosine: Insights into microbial pathogenesis. Nitric Oxide. 2006;14(2):101-8. [DOI:10.1016/j.niox.2005.10.004] [PMID]

11. Liaudet L, Soriano FG, Szabó C. Biology of nitric oxide signaling. Crit Care Med. 2000; 28(4 Suppl): N37-52. [DOI:10.1097/00003246-200004001-00005] [PMID]

12. Rapid Dengue Test Kit - highly sensitive [Internet]. JMitra & Co. Pvt. Ltd. Available from: [https://jmitra.co.in/product-details/dengue-day-1-rapid-test-kit/]

13. Organization WH. Dengue Guidelines for Diagnosis Treatment, Prevention and Control A joint publication of the World Health Organization (WHO) and the Special Programme for Research and Training in Tropical Diseases (TDR) 2009.

14. Kasper D, Fauci A, Hauser S, Longo D, Jameson J, Loscalzo J. Harrison's principles of internal medicine. 19 ed: Mcgraw-hill New York, NY, USA; 2015.

15. Organization WH. Dengue guideline, for diagnosis, treatment, prevention and control Who. 2009.

16. Jameson JL, Fauci A, Kasper D, Hauser S, Longo D, Loscalzo J. Harrison's Principles of Internal Medicine. 20, editor2022.

17. Bryan NS, Grisham MB. Methods to detect nitric oxide and its metabolites in biological samples. Free Radic Biol Med. 2007;43(5):645-57. [DOI:10.1016/j.freeradbiomed.2007.04.026] [PMID] [PMCID]

18. Quijano C, Romero N, Radi R. Tyrosine nitration by superoxide and nitric oxide fluxes in biological systems: Modeling the impact of superoxide dismutase and nitric oxide diffusion. Free Radic Biol Med. 2005;39(6):728-41. [DOI:10.1016/j.freeradbiomed.2005.04.014] [PMID]

19. Thai KTD, Nishiura H, Hoang PL, Tran NTT, Phan GT, Le HQ, et al. Age-Specificity of Clinical Dengue during Primary and Secondary Infections. PLoS Negl Trop Dis. 2011;5(6):e1180. [DOI:10.1371/journal.pntd.0001180] [PMID] [PMCID]

20. Kumar A, Pandit VR, Shetty S, Pattanshetty S, Krish SN, Roy S. A profile of dengue cases admitted to a tertiary care hospital in Karnataka, southern India. Trop Doct. 2010;40(1):45-6. [DOI:10.1258/td.2009.080376] [PMID]

21. Tejaswi CN, Patil SS, Shekharappa KR. Study of clinical manifestations of dengue cases in a tertiary care hospital, Bangalore, Karnataka. Int J Medical Sci Public Health. 2016;5(12):2503-7. [DOI:10.5455/ijmsph.2016.07052016504]

22. Ojha A, Nandi D, Batra H, Singhal R, Annarapu GK, Bhattacharyya S, et al. Platelet activation determines the severity of thrombocytopenia in dengue infection. Sci Rep. 2017;7(1):41697. [DOI:10.1038/srep41697] [PMID] [PMCID]

23. Raj AS, Munshi S, Shah BH. A study on clinical presentation of dengue fever in children. Int J Sci Res. 2016;5(4):2272-5. [DOI:10.21275/v5i4.NOV163048]

24. Rodhain F, Rosen L. Mosquito vectors and dengue virus-vector relationships. In: Gubler DJ, Kuno G. Dengue and Dengue Hemorrahgic Fever. CAB International, New York: USA. 1997. pp.45-60.

25. Valero N, Espina L, Torres E, Mosquera J. increased level of serum nitric oxide in patients with dengue. Am J Trop Med Hyg. 2002;66(6): 762-4. [DOI:10.4269/ajtmh.2002.66.762] [PMID]

26. Marianneau P, Steffan AM, Royer C, Drouet MT, Jaeck D, Kirn A, et al. Interaction of dengue virus with human kupffer cells in vitro. Biol Cell. 1999; 91(3):280. [DOI:10.1016/S0248-4900(99)80058-6]

27. Mukerjee R, Misra A, Chaturvedi UC. Dengue virus‐induced cytotoxin releases nitrite by spleen cells. Int J Exp Pathol. 1996;77(2):45-51. [DOI:10.1046/j.1365-2613.1996.962100.x] [PMID] [PMCID]